当前位置：
首页
>
产品中心 >
Other_animal_antigens >
Excellgen/HIF-1a NTAD (Hypoxia-Inducible Factor 1 alpha N-Terminal Activation Domain (530-698)/RP-120/10,000 U
Excellgen/HIF-1a NTAD (Hypoxia-Inducible Factor 1 alpha N-Terminal Activation Domain (530-698)/RP-120/10,000 U
市场价：
¥5000.00
美元价：
2250.00
产品分类：
其它动物抗原
公司分类：
Other_animal_antigens
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
| ProductName | HIF-1aNTAD(Hypoxia-InducIBLeFactor1alphaN-TerminalActivationDomain(530-698) |
| Size | 10,000U |
| Description | Hypoxia-induciblefactor-1(HIF1)isatranscriptionfactorfoundinmammaliancellsculturedunderreducedoxygentensionthatplaysanessentialroleincellularandsystemichomeostaticresponsestohypoxia.HIF1isaheterodimercomposedofanalphasubunitandabetasubunit.Thebetasubunithasbeenidentifiedasthearylhydrocarbonreceptornucleartranslocator(ARNT).ThisgeneencodesthealphasubunitofHIF-1.HIF-1alphacontainstwotransactivationdomainslocatedbetweenaminoacids531and826.Overexpressionofanaturalantisensetranscript(aHIF)ofthisgenehasbeenshowntobeassociatedwithnonpapillaryrenalcarcinomas.Twoalternativetranscriptsencodingdifferentisoformshavebeenidentified.SpecificdisruptionoftheHIF-1pathwayisimportantforexploringitsroleintumorBIOLOGyanddevelopingmoreefficientweaponstotreatcancer(1).HIF-1alphaisamasterregulatorofthehypoxicresponse,anditsproangiogenicactivitiesinclude,butarenotlimitedto,regulationofvascularendothelialgrowthfactor(VEGF)(2).HIF-1alphaproteinexpressionoftenseenininvasivebreastcancer(3).RecentdatademonstratesthatHIF-1alphaknockdownreducestumOrigenicityofMCF-7cellsandsuggestapromisingcombinationofbothanti-HIF-1strategyandtrADItionalchemotherapytoimprovecancertreatment(4) |
| Applications |
|
| Source | E.coli |
| FusionTag | 6XHis |
| PurificationMethod | FPLC |
| UnitDefinition(Activity) | 1unitequalsto1nanogramofpurifiedprotein |
| Purity | ~95%asdeterminedbySDS-PAGE |
| GeneID | 3091 |
| Accession# | NM_001530 |
| GeneName | hypoxiainduciblefactor1,alphasubunit(basichelix-loop-helixtranscriptionfactor) |
| GeneSymbol | HIF1A |
| GeneSynonyms | HIF1;MOP1;PASD8;HIF-1A;bHLHe78;HIF-1alpha;HIF1-ALPHA |
| MW | 19.8kDa |
| ProteinSequence | EFKLELVEKLFAEDTEAKNPFSTQDTDLDLEMLAPYIPMDDDFQLRSFDQLSPLESSSASPESASPQSTVTVFQQTQIQEPTANATTTTATTDELKTVTKDRMEDIKILIASPSPTHIHKETTSATSSPYRDTQSRTASPNRAGKGVIEQTEKSHPRSPNVLSVALSQRTT |
| StorageBuffer | 20mMTris-Cl(pH8.0),20%Glycerol,100mMKCl,1mMDTTand0.2mMEDTA |
| Storage | -20to-80°C. |
| Shipping | 4°Cordryice |
| References | 1.Semenza,G.L.etal.,(1994)J.Biol.Chem.269(38),23757-23763 2.Corley,K.M.etal.,(2005)J.Cell.Biochem.96(5),971-985 3.Vleugel,M.M.,etal.,(2005)CancerGenet.Cytogenet.163(2),168-172 4.Li,J.,etal.(2006)Biochem.Biophys.Res.Commun.342(4),1341-1351 |
品牌介绍
ExcelGene是一家私人拥有和科学驱动的公司，由Florian M.Wurm教授于2001年创建，自2017年起由首席执行官Maria João Wurm博士领导。我们的总部设在瑞士的蒙蒂。F、 Wurm是旧金山南部基因科技公司（Genentech Inc.）的前经理和科学家，也是为第一批在CHO细胞中制造药物蛋白质而开发制造工艺的先驱科学家之一。Maria J.De Jesus，现在的Maria J.Wurm，ExcellGene的共同创始科学家，在位于洛桑的瑞士联邦理工学院（EPFL）担任高级科学家，发明并开发了多项突破性技术。这些发明对细胞系的发展产生了深远的影响，有些已经在临床生物制剂的早期研发工作中得到了全球应用。ExcelGene面向全球客户，致力于挑战蛋白质表达目标。
